Moderna Begins Testing Vaccine for Epstein-Barr — the Virus That May Be Behind MS | MyMSTeam

Connect with others who understand.

sign up Log in
Resources
About MyMSTeam
Powered By
MULTIPLE SCLEROSIS
NEWS

Moderna Begins Testing Vaccine for Epstein-Barr — the Virus That May Be Behind MS

Medically reviewed by Amit M. Shelat, D.O.
Written by Torrey Kim
Posted on February 18, 2022
(Adobe Stock)


Biotechnology company Moderna Therapeutics has launched the first phase of a clinical trial to evaluate its vaccine for Epstein-Barr virus (EBV), dosing the first study participant on Jan. 5. Currently, no effective vaccine exists to prevent EBV, the virus that some scientists believe could trigger multiple sclerosis (MS).

EBV is a known cause of mononucleosis, a disease that’s common among teens. In addition, scientists believe that EBV may be “the leading cause of MS,” according to a study published in January, which analyzed data from more than 10 million members of the U.S. military. After reviewing 20 years’ worth of medical records, the researchers found a 32-fold higher MS risk following infection with EBV.

Moderna is in the early stages of its Eclipse Trial, which is evaluating outcomes of the vaccine in healthy people between the ages of 18 and 30 years of age. The vaccine uses messenger RNA (mRNA) technology, the same platform that Moderna uses in its COVID-19 vaccines.

Moderna is not the only company evaluating EBV vaccines, and inoculations against Epstein-Barr have been in development for years. Moderna’s technology aims to boost the immune system to prevent infection with EBV.

“In addition to using the mRNA platform, this vaccine differs from other EBV vaccines in development because it incorporates four glycoproteins expressed on the virus’ external surface that are used by the virus to enter cells,” said Dr. Katherine Luzuriaga, principal investigator for the study at UMass Chan Medical School, in a statement about the trial. “The goal is to raise robust immune responses to a broader range of proteins used by the virus for cell entry, in order to protect against infection and mononucleosis disease.”

Modern is still recruiting candidates to participate in the trial. More information is available here.

Posted on February 18, 2022
All updates must be accompanied by text or a picture.

Become a Subscriber

Get the latest news about multiple sclerosis sent to your inbox.

Amit M. Shelat, D.O. is a fellow of the American Academy of Neurology and the American College of Physicians. Review provided by VeriMed Healthcare Network. Learn more about him here
Torrey Kim is a freelance writer with MyHealthTeam. Learn more about her here

Recent Articles

If you have multiple sclerosis (MS) and want to switch treatments, you may need to wait for one d...

MS DMTs and Washout Periods: 8 Facts To Know

If you have multiple sclerosis (MS) and want to switch treatments, you may need to wait for one d...
Explore how others with multiple sclerosis experience shoulder pain and what they recommend to tr...

Shoulder Pain and MS: Members Describe Symptoms and Share Tips

Explore how others with multiple sclerosis experience shoulder pain and what they recommend to tr...
Read on to find out possible causes of neck, jaw, or collarbone pain, and how others with MS have...

MS and Pain in the Collarbone, Neck, and Jaw

Read on to find out possible causes of neck, jaw, or collarbone pain, and how others with MS have...
Part of the Relapsing MS Playbook seriesEnter Cell 2 Content Here...Enter Cell 3 Content Here...E...

MS and Cold Sensitivity: How Does Cold Affect MS Symptoms?

Part of the Relapsing MS Playbook seriesEnter Cell 2 Content Here...Enter Cell 3 Content Here...E...
Learn how to manage MS symptoms and prepare for your doctor appointments.

Relapsing MS Playbook

Learn how to manage MS symptoms and prepare for your doctor appointments.
Part of the Relapsing MS Playbook seriesEnter Cell 2 Content Here...Enter Cell 3 Content Here...E...

Your Relapsing MS Checklist: Custom Questions About Symptoms and Self-Care

Part of the Relapsing MS Playbook seriesEnter Cell 2 Content Here...Enter Cell 3 Content Here...E...
MS News
MS News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close